The 21st Century Cures Act was signed into law in Dec. 2016 and authorizes $1.8 billion over 7 years to fund the Beau Biden Cancer Moonshot. In response to recommendations provided in the Blue-Ribbon Panel report, the National Cancer Institute has established implementation teams to consider multiple ways to fund Cancer Moonshot-related research. The teams have identified nine upcoming scientific opportunities that directly address the goals of the Cancer Moonshot: Immuno-Oncology Translational Network (IOTN), Pediatric Immunotherapy Discovery and Development Network (PI-DDN), Mechanisms of Cancer Drug Resistance and Sensitivity Network Coordinating Center, Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers, Common Terminology Criteria for Adverse Events (CTCAE) and Patient Reported Outcomes-CTCAE (PRO-CTCAE), Improving Management of Symptoms Across Cancer Treatments (IMPACT), Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes, Accelerating Colorectal Cancer Screening and Follow-Up Through Implementation Science (ACCSIS), and Human Tumor Atlas (HTA) Network.
Read more